JapanStake
Pharmaceutical · Fiscal year end Dec 31

MIZUHO MEDY CO.,LTD.

4595

株式会社ミズホメディー

FIGI BBG001BDHBD94595.T4595 JPCorp. no. 2300001006311

Latest half-year results

First half · fiscal year to 2026-12 · filed 2026-08-12

For the first half of the fiscal year to 2026-12: Revenue ¥3.5 billion (-11.1% YoY), Ordinary income ¥1.1 billion (-20.5% YoY), Net income ¥0.8 billion (-19.4% YoY).

This periodYear on year
Revenue¥3.5bn-11.1%
Ordinary profit¥1.1bn-20.5%
Net profit to owners¥822m-19.4%

From the securities report on EDINET, which states no forecast. History via /v1/companies/4595/earnings-releases.

Financials

Japan GAAP · non-consolidated · fiscal year to 2025-12-31
Revenue
¥11.3bn
Net income
¥3.4bn
ROE
19.0%
Equity ratio
83.5%
Dividend / share
¥100
Employees
193
Revenue · ¥bn
FY2021: ¥13.1bn 13.1 FY2021FY2022: ¥17.6bn 17.6 FY2022FY2023: ¥11.0bn 11 FY2023FY2024: ¥11.4bn 11.4 FY2024FY2025: ¥11.3bn 11.3 FY2025
Net income · ¥bn
FY2021: ¥4.8bn 4.82 FY2021FY2022: ¥7.8bn 7.84 FY2022FY2023: ¥3.8bn 3.77 FY2023FY2024: ¥3.8bn 3.77 FY2024FY2025: ¥3.4bn 3.43 FY2025
Fiscal yearRevenueNet incomeTotal assetsNet assetsROEEPSOperating CF
2025-12-31¥11.3bn¥3.4bn¥22.4bn¥18.7bn19.0%¥179.84¥2.0bn
2024-12-31¥11.4bn¥3.8bn¥20.7bn¥17.4bn22.9%¥198.12¥3.3bn
2023-12-31¥11.0bn¥3.8bn¥18.9bn¥15.7bn25.2%¥198.13¥4.0bn
2022-12-31¥17.6bn¥7.8bn¥19.1bn¥14.3bn70.3%¥411.47¥6.2bn
2021-12-31¥13.1bn¥4.8bn¥12.2bn¥8.0bn81.6%¥252.86¥5.6bn

Indicators

Computed by us from filings · fiscal year to 2025-12-31
MetricValuePercentile among listed companies
ROE, %1986.4
Ordinary margin0.420698.9
Equity ratio, %83.593.4
Revenue growth-0.014819.7
Net income growth-0.092228.6
Operating cash flow / assets0.087465.9
Policy-uncertainty measure0.50 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.
Trade & tariffs 1 Politics & geopolitics 1
Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 2.1% held by other listed companies.

Results wording balance: -0.11. Proprietary text method; it describes the wording only and does not interpret context.

Via /v1/companies/4595/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them
Internal control, 2026-03-26: see filing 上記の評価の結果、当事業年度末日時点において、当社の財務報告に係る内部統制は有効であると判断いたしました。 Filing

Segments, votes and tender offers

Stated in EDINET filings
Latest voting result: 2026-03-27 · 剰余金の処分の件 · passed. /v1/companies/4595/voting

Ownership changes

All companies →
  • 2025-01-06
    Decrease−1.97pt

    individual filer reduced holdings in MIZUHO MEDY CO.,LTD. (4595) to 20.99% from 22.96%.

    01020304050
    S100V1F9Original filing (PDF, Japanese)
  • 2024-12-10
    Decrease−13.87pt

    individual filer reduced holdings in MIZUHO MEDY CO.,LTD. (4595) to 22.96% from 36.83%.

    01020304050
    S100UT59Original filing (PDF, Japanese)
  • 2024-12-10
    Threshold

    Holdings of individual filer in MIZUHO MEDY CO.,LTD. (4595) moved below 33.4% (36.83% -> 22.96%).

    01020304050
    S100UT59Original filing (PDF, Japanese)

Trades by 5% holders

From the 60-day trade tables in 5% reports
¥1,445¥1,445¥1,445 2024-12-032024-12-25 2024-12-25 · sold 375,000 @ ¥1,445 · individual filer2024-12-03 · sold 2,500,000 @ ¥1,445 · individual filer
Bought SoldHover a dot for the trade
HolderPeriodNet sharesNet % of sharesAvg. filed priceRange
individual filer2024-12-03 – 2024-12-25-2,875,000−15.09pt¥1,445¥1,445–1,445

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4595/trades.

5% filings

Large shareholding reports on 4595
FiledFilerStakeChangeStated purpose
2025-01-06individual filer20.99%−1.97pt—
2024-12-10individual filer22.96%−13.87pt—

Cross-shareholdings

From the annual report's status of shareholdings
Listed strategic holdings
1 issues
Book value
¥1m
Sold in the year
— — issues
Bought in the year
— — issues
Mutual, both reports
0
Held by listed cos.
1
HoldsBook valueShares vs. prior yearMutual
VITAL KSK HOLDINGS,INC. 3151¥1m0.0%no

Held by: Nishi-Nippon Financial Holdings, Inc. 7189

Purposes, all holdings and mutual flags via /v1/companies/4595/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2025-12-31
ShareholderSharesRatio
individual holder3,914,00020.54%
ミズホメディー社員持株会426,0002.23%
株式会社西日本シティ銀行400,0002.09%
三菱UFJeスマート証券株式会社309,0001.62%
BNY GCM CLIENT ACCOUNT JPRD AC ISG (FE-AC)257,0001.35%
BNYM SA/NV FOR BNYM FOR BNY GCM CLIENT ACCOUNTS M LSCB RD243,0001.27%
モルガン・スタンレーMUFG証券株式会社224,0001.17%
individual holder212,0001.11%
individual holder208,0001.09%
individual holder200,0001.04%

U.S. funds holding 4595

SEC Form N-PORT, reports to 2026-07-31

25 U.S. funds held 432,100 shares worth $4.5m.

FundSharesValue% of fundAs of
Avantis International Small Cap Value ETF
American Century ETF Trust
75,700$0.8m0.004%2026-05-31
THE JAPANESE SMALL COMPANY SERIES
DFA INVESTMENT TRUST CO
76,200$0.8m0.020%2026-07-31
INTERNATIONAL CORE EQUITY 2 PORTFOLIO
DFA INVESTMENT DIMENSIONS GROUP INC
56,800$0.6m0.001%2026-07-31
iShares International Small-Cap Equity Factor ETF
iShares Trust
43,600$0.5m0.070%2026-07-31
WisdomTree Dynamic International Equity Fund
WisdomTree Trust
28,600$0.3m0.020%2026-06-30

Up to 25 funds per stock via the API.

Get this as JSON

GET /v1/companies/4595
GET /v1/companies/4595/financials
GET /v1/companies/4595/details
GET /v1/companies/4595/segments
GET /v1/companies/4595/voting
GET /v1/companies/4595/tender-offers
GET /v1/companies/4595/indicators
GET /v1/companies/4595/earnings-releases
GET /v1/events?ticker=4595
GET /v1/companies/4595/trades         
GET /v1/companies/4595/cross-holdings 
GET /v1/companies/4595/brief

Plans from $9 a month · Documentation